Forecast: (MLTX) for today January 18 & Weekly Forecast from 14 January to 20 January
MoonLake Immunotherapeutics icon

Forecast: (MLTX) for today January 18 & Weekly Forecast from 14 January to 20 January

Updated: January 18, 2024


Brief information about MoonLake Immunotherapeutics

Ticker: MLTX

Sector: Life sciences

Closing price of the last trading day: $56.41

Last trading day: 01/17/2024

Analyst forecast price: $69.25

52-week high/low: $63.77 / $10.5

Shares of MoonLake Immunotherapeutics are traded on the stock exchange under the ticker MLTX, marking their space in the competitive "Life sciences" sector. For stakeholders, tracking the dynamic price movement of MLTX is crucial for making informed investment decisions. In a market influenced by myriad factors, predicting the trajectory of these shares becomes both a challenge and a necessity. Predictive analytics and data-driven insights play a pivotal role in forecasting the performance of MLTX. The investors seeking up-to-date and accurate forecasts for MoonLake Immunotherapeutics shares can turn to resources like Allforecast.com. The website stands out as a reliable tool offering real-time predictions, ensuring that investors are equipped with current and anticipated stock trends. On Allforecast.com, users gain access to a comprehensive analysis and predictions specifically tailored for MLTX, spanning varied timeframes - from the next day's anticipations to weekly, monthly, and yearly forecasts. The platform’s real-time updating mechanism ensures that the forecasted data aligns with the ongoing market trends and economic shifts, offering users actionable insights to optimize their investment strategies. The forecasts integrate a mix of qualitative and quantitative analyses, sector-specific trends within "Life sciences", and broader market dynamics to present a holistic view of MLTX's expected performance. By leveraging such precise and timely data, investors can strategize their moves, balancing risks and opportunities associated with MoonLake Immunotherapeutics's stocks. Navigating through the unpredictable terrains of the stock market requires actionable insights and timely data. Allforecast.com serves as a companion for investors eyeing MLTX, offering them a blend of accuracy and timeliness in predicting stock movements, aiding in informed and strategic investment choices.

Main Headquarters: Situated at C/O CORMORANT ASSET MANAGEMENT, LLP, 200 CLARENDON STREET FL 52, BOSTON, MA, US, this location serves as the primary hub for all corporate activities.

MoonLake Immunotherapeutics's Current Market Value: As of our last update, it's pegged at $3 456 169 000, indicating its standing in the financial landscape.

Shares Overview: Currently, 59 940 000 shares of MoonLake Immunotherapeutics are actively traded and held by the public.

Last year's EBITDA (Earnings Before Interest, Taxes, and Depreciation) for MoonLake Immunotherapeutics stood at -55 777 468$. This figure provides insights into the company's operational profitability. On the other hand, a negative EBITDA hints at MoonLake Immunotherapeutics's current challenges in achieving profitability.

In addition to fundamental factors, stocks are influenced by many other factors. For example, it is worth monitoring all global forecasts for MoonLake Immunotherapeutics shares. Our service will help you with this, in which we collect all forecasts and build one consensus forecast from them.



MoonLake Immunotherapeutics stock forecast

When considering an investment in MoonLake Immunotherapeutics, prospective investors often seek insights on its long-term performance. Our platform consolidates the expert analyses and projections from renowned global analysts to offer a unified consensus forecast for 2024, 2025, 2026, 2027, and 2028.

With these forecasts at your disposal, you can address critical questions like:

What will be the price of one share of MoonLake Immunotherapeutics in the subsequent years including 2024, 2025, 2026, 2027, and 2028?

What consensus have the analysts reached regarding the future performance of MoonLake Immunotherapeutics stock?

Is MoonLake Immunotherapeutics stock a viable option for both short-term and long-term investment?

Is it prudent to sell or hold MoonLake Immunotherapeutics shares in 2024?

Is 2024 the opportune moment to buy MoonLake Immunotherapeutics stock, or is patience a more viable strategy?

What are the anticipated entry and exit points for investing in MoonLake Immunotherapeutics stock, according to expert forecasts?

It’s pivotal to remember that these forecasts are to be utilized as informational resources and not definitive investment advice. The final investment decision rests solely upon the investor, contingent on their risk tolerance, investment goals, and thorough analysis of MoonLake Immunotherapeutics.

Insight into Our Forecasting Process

Our forecasting methodology encompasses the aggregation of public and expert data on MoonLake Immunotherapeutics, coupled with a sophisticated algorithm that calculates a weighted average forecast while eliminating outliers. This ensures that our audience receives a refined and realistic projection of MoonLake Immunotherapeutics stock’s future performance.

MoonLake Immunotherapeutics Daily Share Price Forecast for One Month

Our team has meticulously gathered and analyzed forecasts from a diverse pool of analysts to present a consolidated average daily forecast for MoonLake Immunotherapeutics shares over the upcoming month. It’s essential to bear in mind that short-term predictions can often be subject to significant volatility, influenced by a myriad of dynamic, real-time market factors.

As you scroll, you’ll discover a detailed graph illustrating the consensus forecast for MoonLake Immunotherapeutics stocks over the next 30 days. The gray spectrum of the chart delineates the historical trajectory of the stock’s price, while the turquoise spectrum provides a visual representation of the anticipated price, inclusive of potential fluctuation ranges, offering insights into prospective market trends and stock behaviors.

In the dynamic world of stock trading, analysts and investors closely observe the projected highs and lows of MoonLake Immunotherapeutics shares. Our integrated forecast predicts a peak price of $70.34 in the forthcoming 30 days, indicating the zenith of the stock's potential performance. An encouraging revelation, denoting an upside potential of 24.69% from the current standing.

On the flip side, the stock might plummet to a minimum of $55.5 within the same period. A decline of 1.64% signals caution, nudging investors towards a more conservative stance.

Consequently, a fluctuation corridor emerges, with the stock’s resistance at $70.34 and support at $55.5, indicating the oscillating nature of MoonLake Immunotherapeutics’s stock over the one-month spectrum. These oscillations, while providing trading opportunities, should be navigated with adept knowledge and strategic foresight.

So, what’s the trajectory of MoonLake Immunotherapeutics amidst these projections? The nuances of stock trading and investment are encapsulated in the constant ebb and flow of the market, influenced by intrinsic and extrinsic factors. Hence, a comprehensive, nuanced understanding of market dynamics, coupled with real-time analytics, emerges as the cornerstone for maximizing ROI and mitigating risks.

The evolution of MoonLake Immunotherapeutics’s stock is akin to a narrative unfolding, shaped by myriad factors including market trends, economic indicators, and investor sentiment. Each fluctuation is a chapter of this narrative, offering insights, challenges, and opportunities to the discerning investor.

Evaluating the resilience of the support level is crucial in gauging the future trajectory of MoonLake Immunotherapeutics shares. The anticipation is that the price will hover near the support level for 5 days. The support level at $55.5 appears to be resilient. However, the volatility in the market and other influencing factors make the downward breach a possibility investors should be wary of.

It’s imperative to remember the innate unpredictability of the stock market. The actual future value of MoonLake Immunotherapeutics shares is subject to variables beyond predictive analytics. Nonetheless, investors can expect the stock to oscillate within the defined optimistic and pessimistic target price brackets, offering both challenges and opportunities for strategic trading and investment.

Forecast table for 30 days
Date Target Pes. Opt. Vol., %
Jan 20 56.73 55.60 58.25 4.78
Jan 21 57.01 55.50 57.78 4.11
Jan 22 56.85 55.87 58.39 4.52
Jan 23 57.37 55.86 59.00 5.63
Jan 24 59.62 59.00 61.05 3.48
Jan 25 60.98 59.37 61.59 3.74
Jan 26 61.05 59.37 62.59 5.43
Jan 27 62.17 60.36 63.32 4.90
Jan 28 60.88 60.03 61.71 2.80
Jan 29 61.12 59.44 62.37 4.94
Jan 30 61.15 60.64 62.89 3.71
Jan 31 60.46 59.38 62.21 4.77
Feb 01 62.47 61.77 64.40 4.25
Feb 02 63.42 62.84 64.36 2.42
Feb 03 64.72 63.45 66.71 5.14
Feb 04 64.92 64.20 66.04 2.87
Feb 05 66.48 64.88 67.33 3.77
Feb 06 67.44 66.04 67.98 2.94
Feb 07 65.85 64.45 67.87 5.31
Feb 08 66.40 64.73 67.20 3.82
Feb 09 65.07 64.24 66.35 3.28
Feb 10 65.54 64.73 66.46 2.67
Feb 11 64.57 64.03 65.96 3.03
Feb 12 65.73 64.47 66.97 3.87
Feb 13 67.10 65.73 68.23 3.80
Feb 14 66.51 65.21 68.13 4.49
Feb 15 67.07 66.32 68.14 2.75
Feb 16 68.33 67.34 69.56 3.29
Feb 17 69.04 67.33 70.34 4.47
Feb 18 67.49 66.63 68.57 2.92

MoonLake Immunotherapeutics Stock Forecast 20 Jan.

Presumably, on 01/20/2024, the price of shares will be in the range of $55.60 - $58.25. A $2.66 range width can provide 4.78% volatility. The weighted average price of this range is at $56.73, which is $0.76 lower than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 21 Jan.

Presumably, on 01/21/2024, the price of shares will be in the range of $55.50 - $57.78. A $2.28 range width can provide 4.11% volatility. The weighted average price of this range is at $57.01, which is $0.27 higher than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 22 Jan.

Presumably, on 01/22/2024, the price of shares will be in the range of $55.87 - $58.39. A $2.52 range width can provide 4.52% volatility. The weighted average price of this range is at $56.85, which is $0.16 lower than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 23 Jan.

Presumably, on 01/23/2024, the price of shares will be in the range of $55.86 - $59.00. A $3.14 range width can provide 5.63% volatility. The weighted average price of this range is at $57.37, which is $0.52 higher than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 24 Jan.

Presumably, on 01/24/2024, the price of shares will be in the range of $59.00 - $61.05. A $2.05 range width can provide 3.48% volatility. The weighted average price of this range is at $59.62, which is $2.25 higher than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 25 Jan.

Presumably, on 01/25/2024, the price of shares will be in the range of $59.37 - $61.59. A $2.22 range width can provide 3.74% volatility. The weighted average price of this range is at $60.98, which is $1.36 higher than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 26 Jan.

Presumably, on 01/26/2024, the price of shares will be in the range of $59.37 - $62.59. A $3.22 range width can provide 5.43% volatility. The weighted average price of this range is at $61.05, which is $0.07 higher than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 27 Jan.

Presumably, on 01/27/2024, the price of shares will be in the range of $60.36 - $63.32. A $2.96 range width can provide 4.90% volatility. The weighted average price of this range is at $62.17, which is $1.12 higher than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 29 Jan.

Presumably, on 01/29/2024, the price of shares will be in the range of $59.44 - $62.37. A $2.93 range width can provide 4.94% volatility. The weighted average price of this range is at $61.12, which is $0.24 higher than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 30 Jan.

Presumably, on 01/30/2024, the price of shares will be in the range of $60.64 - $62.89. A $2.25 range width can provide 3.71% volatility. The weighted average price of this range is at $61.15, which is $0.02 higher than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 31 Jan.

Presumably, on 01/31/2024, the price of shares will be in the range of $59.38 - $62.21. A $2.83 range width can provide 4.77% volatility. The weighted average price of this range is at $60.46, which is $0.68 lower than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 01 Feb.

Presumably, on 02/01/2024, the price of shares will be in the range of $61.77 - $64.40. A $2.62 range width can provide 4.25% volatility. The weighted average price of this range is at $62.47, which is $2.01 higher than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 02 Feb.

Presumably, on 02/02/2024, the price of shares will be in the range of $62.84 - $64.36. A $1.52 range width can provide 2.42% volatility. The weighted average price of this range is at $63.42, which is $0.95 higher than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 03 Feb.

Presumably, on 02/03/2024, the price of shares will be in the range of $63.45 - $66.71. A $3.26 range width can provide 5.14% volatility. The weighted average price of this range is at $64.72, which is $1.29 higher than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 04 Feb.

Presumably, on 02/04/2024, the price of shares will be in the range of $64.20 - $66.04. A $1.84 range width can provide 2.87% volatility. The weighted average price of this range is at $64.92, which is $0.21 higher than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 05 Feb.

Presumably, on 02/05/2024, the price of shares will be in the range of $64.88 - $67.33. A $2.45 range width can provide 3.77% volatility. The weighted average price of this range is at $66.48, which is $1.56 higher than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 06 Feb.

Presumably, on 02/06/2024, the price of shares will be in the range of $66.04 - $67.98. A $1.94 range width can provide 2.94% volatility. The weighted average price of this range is at $67.44, which is $0.96 higher than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 07 Feb.

Presumably, on 02/07/2024, the price of shares will be in the range of $64.45 - $67.87. A $3.42 range width can provide 5.31% volatility. The weighted average price of this range is at $65.85, which is $1.59 lower than the previous day's weighted average price.

MoonLake Immunotherapeutics Stock Forecast 08 Feb.

Presumably, on 02/08/2024, the price of shares will be in the range of $64.73 - $67.20. A $2.47 range width can provide 3.82% volatility. The weighted average price of this range is at $66.40, which is $0.55 higher than the previous day's weighted average price.

Read more

MoonLake Immunotherapeutics monthly stock forecast for 2024, 2025, 2026, 2027, 2028.

Table of forecasts for 2024.
Month Target Pes. Opt. Vol., %
Feb. 54.63 53.65 55.81 3.88
Mar. 56.60 52.73 60.32 12.58
Apr. 55.02 53.49 58.19 8.08
May. 55.07 53.04 57.75 8.15
Jun. 52.59 49.04 55.48 11.60
Jul. 53.96 51.54 55.71 7.50
Aug. 58.29 54.35 59.76 9.04
Sep. 58.92 55.89 63.00 11.28
Oct. 61.30 57.22 65.33 12.41
Nov. 62.02 59.68 64.03 6.80
Dec. 64.25 60.73 68.76 11.69

Diving into a more comprehensive insight, the monthly consensus forecast is an instrumental resource for investors eyeing MoonLake Immunotherapeutics's performance metrics. These projections are meticulously curated, leveraging insights from renowned global analysts and offering a panoramic view of the anticipated stock behaviour for the current year and beyond.

In the mid-term analysis, forecasting accuracy enhances, attributed to the diminished influence of transient market fluctuations. For this year, the zenith of MoonLake Immunotherapeutics share’s value is anticipated to touch $68.76, offering a robust metric for investment strategies, sans the extremes of varied agency forecasts.

On the contrary, the nadir projections settle at $49.04, delineating the lower threshold and offering a holistic perspective on the risk and return landscape.

Progressing further, we have extrapolated these analytical insights to generate consensus forecasts for subsequent years. The synthesized data, presented in intuitive tabular formats, offers investors, analysts, and enthusiasts a streamlined view into the future of MoonLake Immunotherapeutics stocks.

Anticipated Trends: MoonLake Immunotherapeutics (MLTX) Monthly Stock Trajectory for 2025

Table of forecasts for 2025.
Month Target Pes. Opt. Vol., %
Jan 63.21 61.05 64.69 5.63
Feb 68.79 66.00 72.19 8.58
Mar 69.59 66.08 71.10 7.05
Apr 72.41 67.72 74.30 8.86
May 70.78 66.45 72.31 8.10
Jun 67.60 63.28 71.79 11.86
Jul 72.83 69.22 74.27 6.80
Aug 77.29 72.14 80.97 10.91
Sep 73.53 68.96 74.99 8.03
Oct 72.14 69.02 75.71 8.83
Nov 72.07 69.54 75.58 7.98
Dec 73.31 70.80 76.54 7.50

MoonLake Immunotherapeutics (MLTX) Monthly Stock Prediction for 2026

Table of forecasts for 2026.
Month Target Pes. Opt. Vol., %
Jan 70.73 68.44 73.79 7.25
Feb 76.27 71.12 79.57 10.61
Mar 74.42 72.01 76.90 6.36
Apr 79.64 75.20 82.80 9.18
May 75.06 72.62 76.47 5.03
Jun 74.25 72.71 77.85 6.61
Jul 72.98 68.38 76.19 10.26
Aug 74.49 69.59 79.65 12.63
Sep 76.16 73.42 79.59 7.75
Oct 78.56 73.12 80.97 9.69
Nov 76.51 73.89 79.75 7.34
Dec 74.03 72.70 76.43 4.88



MoonLake Immunotherapeutics (MLTX) Monthly Stock Prediction for 2027

Table of forecasts for 2027.
Month Target Pes. Opt. Vol., %
Jan 78.03 72.97 81.96 10.97
Feb 75.08 73.05 76.57 4.59
Mar 72.24 70.62 75.95 7.02
Apr 72.11 68.35 74.51 8.27
May 68.09 64.66 71.46 9.52
Jun 62.76 58.92 64.85 9.15
Jul 61.80 59.07 65.36 9.62
Aug 61.96 60.40 65.70 8.06
Sep 65.81 64.03 69.54 7.92
Oct 67.17 64.39 69.95 7.95
Nov 72.25 67.51 77.45 12.85
Dec 76.02 73.77 77.94 5.36

MoonLake Immunotherapeutics (MLTX) Monthly Stock Prediction for 2028

Table of forecasts for 2028.
Month Target Pes. Opt. Vol., %
Jan 79.79 76.12 82.95 8.22
Feb 79.28 77.86 82.92 6.11
Mar 81.42 76.30 86.04 11.33
Apr 84.06 82.32 87.47 5.88
May 85.95 80.38 90.21 10.89
Jun 83.09 79.80 86.53 7.78
Jul 82.34 77.75 86.57 10.19
Aug 75.45 71.45 80.82 11.60
Sep 74.43 71.15 79.66 10.68
Oct 78.52 75.91 79.93 5.04
Nov 85.30 83.61 87.45 4.39
Dec 91.06 85.82 96.47 11.04


Denial of responsibility:

All submitted consensus forecasts are exposed to get acquainted with the algorithm for collecting forecasts and bringing them to a single whole. The portal allforecast.com is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.